{"id":789487,"date":"2023-10-10T18:18:44","date_gmt":"2023-10-10T22:18:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/"},"modified":"2023-10-10T18:18:44","modified_gmt":"2023-10-10T22:18:44","slug":"tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/","title":{"rendered":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence<\/b><\/p>\n<p>WARREN, N.J.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nTevogen Bio Inc (\u201cTevogen Bio\u201d) announces the inception of Tevogen.ai, a new initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg\" alt=\"\" \/><\/div>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftevogen.ai%2F&amp;esheet=53591336&amp;newsitemid=20231010880299&amp;lan=en-US&amp;anchor=Tevogen.ai&amp;index=1&amp;md5=7b55f8589060fdfe7c4dff1ede10acc4\">Tevogen.ai<\/a> will bring together a dedicated team of research scientists, physicians, data scientists, and AI\/machine learning (ML) engineers committed to the ethical development and commercialization of AI-driven and AI-enhanced tools designed to streamline processes and improve health outcomes.<\/p>\n<p>\n\u201cThe launch of Tevogen.ai signifies more than just the inception of a new initiative. It is a testament to our vision of pushing the boundaries of what is achievable in medicine. Through the combination of our biotech expertise and AI\u2019s capabilities, we believe we are setting the stage for significant advancements in healthcare,\u201d stated Ryan Saadi, MD, MPH, CEO of Tevogen Bio.<\/p>\n<p><b>About Tevogen Bio<\/b><\/p>\n<p>\nTevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen\u2019s leadership believes that accessible personalized immunotherapies are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation in the post-pandemic world.<\/p>\n<p><b>Forward Looking Statements<\/b><\/p>\n<p>\nThis press release contains certain forward-looking statements relating to the Tevogen Bio and its business, including without limitation statements regarding Tevogen Bio\u2019s plans for and the potential benefits of Tevogen.ai and the product candidates, products, markets, and expected future performance and market opportunities of Tevogen Bio. These statements are based on management\u2019s current expectations and beliefs as of the date of this release and are subject to several factors which involve known and unknown risks, delays, uncertainties, and other factors not under Tevogen Bio\u2019s control that may cause actual results, performance or achievements to be materially different from the results, performance or other expectations implied by these forward-looking statements. Forward-looking statements can sometimes be identified by terminology such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201cbelieve,\u201d \u201cpotential,\u201d and \u201cpossible,\u201d or their negatives or comparable terminology, as well as other words and expressions referencing future events, conditions, or circumstances. In any forward-looking statement in which Tevogen Bio expresses an expectation or belief as to future results, there can be no assurance that the statement or expectation or belief will be achieved. Various factors may cause differences between Tevogen Bio\u2019s expectations and actual results, including, among others: changes in the markets in which Tevogen Bio competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen Bio may not be able to execute its growth strategies; Tevogen Bio\u2019s limited operating history; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review and approval and commercial development; risks associated with intellectual property protection; and other risks related to matters that could affect Tevogen Bio\u2019s future financial results, including the commercial potential, sales, and pricing of Tevogen Bio\u2019s products. Except as required by law, Tevogen Bio undertakes no obligation to update the forward-looking statements or any of the information in this release, or provide additional information, and expressly disclaims any and all liability and makes no representations or warranties in connection herewith or with respect to any omissions therefrom.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20231010880299r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/<\/a><\/span><\/p>\n<p>\nTevogen Bio Communications<br \/>\n<br \/>T: 1 877 TEVOGEN, Ext 701<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Communications@Tevogen.com\">Communications@Tevogen.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America New Jersey<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Pharmaceutical Technology Artificial Intelligence<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911946\/3\/Tevogen_Logo_Businesswire.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/3\/Tevogen_AI_Logo.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence WARREN, N.J.&#8211;(BUSINESS WIRE)&#8211; Tevogen Bio Inc (\u201cTevogen Bio\u201d) announces the inception of Tevogen.ai, a new initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/ Tevogen.ai will bring together a dedicated team of research scientists, physicians, data scientists, and AI\/machine learning (ML) engineers committed to the ethical development and commercialization of AI-driven and AI-enhanced tools designed to streamline processes and improve health outcomes. \u201cThe launch of Tevogen.ai signifies more than just the inception of a new initiative. It is a testament to our &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-789487","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence WARREN, N.J.&#8211;(BUSINESS WIRE)&#8211; Tevogen Bio Inc (\u201cTevogen Bio\u201d) announces the inception of Tevogen.ai, a new initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/ Tevogen.ai will bring together a dedicated team of research scientists, physicians, data scientists, and AI\/machine learning (ML) engineers committed to the ethical development and commercialization of AI-driven and AI-enhanced tools designed to streamline processes and improve health outcomes. \u201cThe launch of Tevogen.ai signifies more than just the inception of a new initiative. It is a testament to our &hellip; Continue reading &quot;Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-10T22:18:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence\",\"datePublished\":\"2023-10-10T22:18:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/\"},\"wordCount\":646,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010880299\\\/en\\\/1911969\\\/4\\\/Tevogen_AI_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/\",\"name\":\"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010880299\\\/en\\\/1911969\\\/4\\\/Tevogen_AI_Logo.jpg\",\"datePublished\":\"2023-10-10T22:18:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010880299\\\/en\\\/1911969\\\/4\\\/Tevogen_AI_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231010880299\\\/en\\\/1911969\\\/4\\\/Tevogen_AI_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/","og_locale":"en_US","og_type":"article","og_title":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence - Market Newsdesk","og_description":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence WARREN, N.J.&#8211;(BUSINESS WIRE)&#8211; Tevogen Bio Inc (\u201cTevogen Bio\u201d) announces the inception of Tevogen.ai, a new initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20231010880299\/en\/ Tevogen.ai will bring together a dedicated team of research scientists, physicians, data scientists, and AI\/machine learning (ML) engineers committed to the ethical development and commercialization of AI-driven and AI-enhanced tools designed to streamline processes and improve health outcomes. \u201cThe launch of Tevogen.ai signifies more than just the inception of a new initiative. It is a testament to our &hellip; Continue reading \"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-10T22:18:44+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence","datePublished":"2023-10-10T22:18:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/"},"wordCount":646,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/","name":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg","datePublished":"2023-10-10T22:18:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231010880299\/en\/1911969\/4\/Tevogen_AI_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-introduces-tevogen-ai-to-enhance-patient-accessibility-and-accelerate-innovation-leveraging-artificial-intelligence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tevogen Bio Introduces Tevogen.ai to Enhance Patient Accessibility and Accelerate Innovation Leveraging Artificial Intelligence"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=789487"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789487\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=789487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=789487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=789487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}